BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30602374)

  • 1. Complement factors C3a and C5a mimick a proinflammatory microenvironment and increase HBV IGRA sensitivity.
    Bröker K; Terzenbach R; Bentzien F; Lüth S; Dammermann W
    J Transl Med; 2019 Jan; 17(1):6. PubMed ID: 30602374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a novel IGRA assay to test T cell responsiveness to HBV antigens in whole blood of chronic Hepatitis B patients.
    Dammermann W; Bentzien F; Stiel EM; Kühne C; Ullrich S; Schulze Zur Wiesch J; Lüth S
    J Transl Med; 2015 May; 13():157. PubMed ID: 25968473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CpG oligonucleotides increase HBV-specific cytokine responses in whole blood and enhance cytokine release assay sensitivity.
    Dammermann W; Dornbrack J; Bröker K; Bentzien F; Lüth S
    J Virol Methods; 2017 Oct; 248():195-201. PubMed ID: 28739303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
    Boni C; Janssen HLA; Rossi M; Yoon SK; Vecchi A; Barili V; Yoshida EM; Trinh H; Rodell TC; Laccabue D; Alfieri A; Brillo F; Fisicaro P; Acerbi G; Pedrazzi G; Andreone P; Cursaro C; Margotti M; Santoro R; Piazzolla V; Brunetto MR; Coco B; Cavallone D; Zhao Y; Joshi A; Woo J; Lau AH; Gaggar A; Subramanian GM; Massetto B; Fung S; Ahn SH; Ma X; Mangia A; Ferrari C
    Gastroenterology; 2019 Jul; 157(1):227-241.e7. PubMed ID: 30930022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses.
    Peng Q; Li K; Sacks SH; Zhou W
    Inflamm Allergy Drug Targets; 2009 Jul; 8(3):236-46. PubMed ID: 19601884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
    Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
    Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower level of complement component C3 and C3a in the plasma means poor outcome in the patients with hepatitis B virus related acute-on-chronic liver failure.
    Li Q; Lu Q; Zhu MQ; Huang C; Yu KK; Huang YX; Zhao X; Luo XG; Zheng JM
    BMC Gastroenterol; 2020 Apr; 20(1):106. PubMed ID: 32293297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-33 Amplifies Human Mast Cell Activities Induced by Complement Anaphylatoxins.
    West PW; Bahri R; Garcia-Rodriguez KM; Sweetland G; Wileman G; Shah R; Montero A; Rapley L; Bulfone-Paus S
    Front Immunol; 2020; 11():615236. PubMed ID: 33597949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent Mechanism.
    van Montfoort N; van der Aa E; van den Bosch A; Brouwers H; Vanwolleghem T; Janssen HLA; Javanbakht H; Buschow SI; Woltman AM
    J Virol; 2016 Jul; 90(14):6187-6199. PubMed ID: 27099316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro- and anti-inflammatory cytokines.
    Schlaak JF; Tully G; Löhr HF; Gerken G; Meyer zum Büschenfelde KH
    Clin Exp Immunol; 1999 Mar; 115(3):508-14. PubMed ID: 10193426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatibility of hemodialysis membranes: interrelations between plasma complement and cytokine levels.
    Varela MP; Kimmel PL; Phillips TM; Mishkin GJ; Lew SQ; Bosch JP
    Blood Purif; 2001; 19(4):370-9. PubMed ID: 11574733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBV-specific lymphoproliferative and cytokine responses in patients with chronic hepatitis B.
    Vingerhoets J; Michielsen P; Vanham G; Bosmans E; Paulij W; Ramon A; Pelckmans P; Kestens L; Leroux-Roels G
    J Hepatol; 1998 Jan; 28(1):8-16. PubMed ID: 9537868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune correlates of hepatitis B surface antigen spontaneous seroconversion in hepatitis B e antigen negative chronic hepatitis B patients.
    Vyas AK; Sharma BC; Sarin SK; Trehanpati N
    Liver Int; 2018 Jan; 38(1):38-49. PubMed ID: 28500636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Hepatic CD1d Levels Coincide with Invariant NKT Cell Defects in Chronic Hepatitis B Virus Infection.
    Tan X; Ding Y; Zhu P; Dou R; Liang Z; Yang D; Huang Z; Wang W; Wu X; Weng X
    J Immunol; 2018 May; 200(10):3530-3538. PubMed ID: 29643189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kupffer cells interact with hepatitis B surface antigen in vivo and in vitro, leading to proinflammatory cytokine production and natural killer cell function.
    Boltjes A; van Montfoort N; Biesta PJ; Op den Brouw ML; Kwekkeboom J; van der Laan LJ; Janssen HL; Boonstra A; Woltman AM
    J Infect Dis; 2015 Apr; 211(8):1268-78. PubMed ID: 25362194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy.
    Pal S; Nandi M; Dey D; Chakraborty BC; Shil A; Ghosh S; Banerjee S; Santra A; Ahammed SKM; Chowdhury A; Datta S
    Aliment Pharmacol Ther; 2019 May; 49(10):1346-1359. PubMed ID: 30982998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells.
    Shivshankar P; Li YD; Mueller-Ortiz SL; Wetsel RA
    FASEB J; 2020 Jun; 34(6):7540-7560. PubMed ID: 32301538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances the hepatitis B virus-specific cytotoxic T-lymphocyte immune response and inhibits hepatitis B virus replication in transgenic mice.
    Zhuo M; Song L; Tang Y; Dai S; Chen X; Yu Y; Zang G; Tang Z
    Mol Med Rep; 2015 Sep; 12(3):3591-3598. PubMed ID: 26004262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T- and B-cell responses and previous exposure to hepatitis B virus in 'anti-HBc alone' patients.
    Wang Q; Sachse P; Semmo M; Lokhande M; Montani M; Dufour JF; Zoulim F; Klenerman P; Semmo N
    J Viral Hepat; 2015 Dec; 22(12):1068-78. PubMed ID: 26075501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on the distribution of CD8+ memory T cell subsets and IFN-γ level during the spontaneous clearance of hepatitis B virus in patients with chronic hepatitis B virus infection.
    Ma XJ; Chen XF; Chen WL; Chen R; Huang J; Luo XD; Liao JY; Chen XP
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4675-4679. PubMed ID: 29131246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.